Raymond James & Associates’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $9.96K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $8.1K | Sell |
|
|||||
|
2023
Q3 | $8.09K | Sell |
|
|||||
|
2023
Q2 | $9.66K | Sell |
|
|||||
|
2023
Q1 | $12.3K | Buy |
|
|||||
|
2022
Q4 | $14.7K | Sell |
|
|||||
|
2022
Q3 | $11K | Hold |
|
|||||
|
2022
Q2 | $18K | Hold |
|
|||||
|
2022
Q1 | $22K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $104K | Sell |
|
|||||
|
2020
Q1 | $57K | Sell |
|
|||||
|
2019
Q4 | $35K | Buy |
|
|||||
|
2019
Q3 | $39K | Buy |
|
|||||
|
2019
Q2 | $89K | Sell |
|
|||||
|
2019
Q1 | $130K | Buy |
|
|||||
|
2018
Q4 | $132K | Buy |
|
|||||
|
2018
Q3 | $195K | Sell |
|
|||||
|
2018
Q2 | $185K | Sell |
|
|||||
|
2018
Q1 | $282K | Buy |
|
|||||
|
2017
Q4 | $114K | Buy |
|